National, Prospective, Multicenter,Observational Registry Study on Pulmonary Hypertension Due to Left Heart Disease in China
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pulmonary Hypertension Due to Left Heart Disease
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Enrollment
- 520
- Locations
- 1
- Primary Endpoint
- All cause death
- Last Updated
- 8 years ago
Overview
Brief Summary
Left heart disease is the main cause of pulmonary hypertension. With the advent of the aging society, chronic heart failure has become a global public health problem. Therefore the prevalence of pulmonary hypertension due to the left heart disease is increasing. However, there is no research on the prevalence of pulmonary hypertension due to the left heart disease in China. Therefore, the aim of the present study was to describe real-world outcome of Chinese patients with pulmonary hypertension due to the left heart disease and identify factors that may predict outcome. Our study will profile the demographics, clinical course, treatments, and outcomes of pulmonary hypertension due to the left heart disease in China.
Investigators
Jianguo He
Director of Pulmonary vascular disease center
Chinese Academy of Medical Sciences, Fuwai Hospital
Eligibility Criteria
Inclusion Criteria
- •Pulmonary Hypertension due to left heart disease
Exclusion Criteria
- •Other forms of Pulmonary Hypertension
- •Heart failure due to valvular heart disease
- •Hypertrophic obstructive cardiomyopathy
- •Right ventricular outflow tract stenosis
- •Pericardial disease
- •Patients with chronic lung disease
Outcomes
Primary Outcomes
All cause death
Time Frame: up to 5 years